Quantcast

Latest Juno Therapeutics Inc. Stories

2014-08-05 08:33:51

Total Investment Tops $300M in Less Than 12 Months SEATTLE, Aug. 5, 2014 /PRNewswire-USNewswire/ -- Juno Therapeutics, Inc., a biotechnology company focused on bringing forward novel immunotherapies for cancer, today announced that it has closed its Series B round with $134M in new investment. http://photos.prnewswire.com/prnvar/20140113/DC45426LOGO This latest round includes new investments by ten public mutual funds and healthcare-focused funds. All major prior investors...

2014-01-13 16:25:48

Juno CEO Hans Bishop to Address JP Morgan's 32nd Annual Healthcare Conference SEATTLE, Jan. 13, 2014 /PRNewswire-USNewswire/ -- Juno Therapeutics, a new biotechnology company focused on bringing forward novel immunotherapies for cancer, announced today an expanded Series A including Bezos Expeditions, the personal investment company of Jeff Bezos, and leading venture capital firm Venrock. The total Series A will exceed $145M. (Logo:...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.